Rajeev Saggar, the Chief Medical Officer of $LQDA ($LQDA), sold 2,445 shares of the company on 01-21-2025 for an estimated $31,785. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.9% of their shares of this class of stock. Following this trade, they now own 267,943 shares of this class of $LQDA stock.
$LQDA Insider Trading Activity
$LQDA insiders have traded $LQDA stock on the open market 27 times in the past 6 months. Of those trades, 2 have been purchases and 25 have been sales.
Here’s a breakdown of recent trading of $LQDA stock by insiders over the last 6 months:
- PAUL B MANNING purchased 337,078 shares for an estimated $2,999,994
- PARTNERS LP CALIGAN has made 1 purchase buying 150,000 shares for an estimated $1,426,500 and 1 sale selling 150,000 shares for an estimated $1,426,500.
- ROGER JEFFS (Chief Executive Officer) has made 0 purchases and 2 sales selling 30,396 shares for an estimated $352,650.
- MICHAEL KASETA (CFO and COO) has made 0 purchases and 4 sales selling 29,432 shares for an estimated $341,337.
- RUSSELL SCHUNDLER (General Counsel) has made 0 purchases and 4 sales selling 20,742 shares for an estimated $240,702.
- RAJEEV SAGGAR (Chief Medical Officer) has made 0 purchases and 4 sales selling 13,480 shares for an estimated $158,767.
- SCOTT MOOMAW (Chief Commercial Officer) has made 0 purchases and 4 sales selling 10,981 shares for an estimated $126,937.
- JASON ADAIR (Chief Business Officer) has made 0 purchases and 6 sales selling 9,157 shares for an estimated $105,098.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$LQDA Hedge Fund Activity
We have seen 80 institutional investors add shares of $LQDA stock to their portfolio, and 64 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CALIGAN PARTNERS LP removed 2,242,353 shares (-21.6%) from their portfolio in Q3 2024, for an estimated $22,423,530
- OPALEYE MANAGEMENT INC. added 1,373,142 shares (+422.5%) to their portfolio in Q3 2024, for an estimated $13,731,420
- KYNAM CAPITAL MANAGEMENT, LP added 1,349,754 shares (+147.3%) to their portfolio in Q3 2024, for an estimated $13,497,540
- FARALLON CAPITAL MANAGEMENT LLC added 1,235,956 shares (+60.1%) to their portfolio in Q3 2024, for an estimated $12,359,560
- WHITEFORT CAPITAL MANAGEMENT, LP added 927,546 shares (+119.8%) to their portfolio in Q3 2024, for an estimated $9,275,460
- FINDELL CAPITAL MANAGEMENT LLC added 793,539 shares (+33.1%) to their portfolio in Q3 2024, for an estimated $7,935,390
- WALLEYE CAPITAL LLC added 535,369 shares (+7667.8%) to their portfolio in Q3 2024, for an estimated $5,353,690
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.